Author response for "An intercountry comparison of the impact of the paediatric live attenuated influenza vaccine (LAIV) programme across the UK and the Republic of Ireland (ROI), 2010 to 2017"

Mary Sinnathamby(Public Health England), Richard Pebody(National Security Agency), Jillian Johnston, Simon de Lusignan(University of Oxford), Lisa Domegan(Health Service Executive), Jim McMenamin(Public Health Scotland), Suzanne Elgohari(UK Health Security Agency), Fiona Warburton(Guy's Hospital), Mark G. O’Doherty(Public Health Agency), Nick Andrews(Environment Agency), Joanna Ellis(Public Health England), Joan O’Donnell(Health Service Executive), Simon Cottrell(Public Health Wales), Ivelina Yonova(University of Surrey), Arlene Reynolds(Health Protection Scotland), Nicki L. Boddington(UK Health Security Agency)

Unknown

January 11, 2023

10.1111/irv.13099/v2/response1

Cited by 0

Related Papers

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

|BMJ|2021|1.4k

First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020

|Eurosurveillance|2020|715

Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium

|BMJ|2015|551

Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data

|The Lancet Digital Health|2021|536

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

|The Lancet|2021|310